Search clinical trials for: Saxagliptin
Total 143 results
-
AstraZenecaCompletedType 2 Diabetes MellitusBrazil
-
AstraZenecaCompletedType 2 Diabetes MellitusUnited States
-
AstraZenecaCompletedType 2 DiabetesUnited States
-
AstraZenecaCompletedType 2 Diabetes MellitusUnited States
-
AstraZenecaCompletedDiabetesKorea, Republic of, Mexico, Taiwan, United States, Argentina, Brazil, Puerto Rico, South Africa, Hong Kong, Israel, Singapore, Peru, Philippines
-
AstraZenecaCompletedDiabetesTaiwan, United States, Russian Federation, India
-
AstraZenecaCompletedDiabetesUnited States, Mexico, Argentina, Brazil, Puerto Rico, Russian Federation, Germany, Italy, Ukraine, India, Hungary, Poland, Philippines
-
AstraZenecaCompletedDiabetes Mellitus, Type 2United States, Chile, Argentina, Brazil, Canada, Mexico, Puerto Rico, Taiwan, Australia
-
Ram WeissUnknownCystic FibrosisIsrael
-
AstraZenecaCompletedDiabetes Mellitus, Type 2United States, Argentina, Canada, Puerto Rico, Mexico, Philippines, India, Peru
-
AstraZenecaCompletedSaxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and ExerciseDiabetes Mellitus, Type 2United States, Canada, Mexico, Puerto Rico, Taiwan, Australia
-
Shanghai Jiao Tong University School of MedicineUnknown
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Shandong Provincial HospitalChinese Medical AssociationUnknown
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes MellitusSweden, United States, Australia, Brazil, Czech Republic, Italy, Mexico, Peru, Poland, Russian Federation, South Africa, Spain, United Kingdom, Germany, China, Hungary, Netherlands, Canada, Hong Kong, Argentina, Chile, France, Israel, Puerto Rico and more
-
National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal TumorUnited States
-
Oslo University HospitalCompleted
-
AstraZenecaWithdrawn
-
University of Erlangen-Nürnberg Medical SchoolCompleted
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes Mellitus(T2DM)China
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes MellitusSweden, Italy, United Kingdom, Finland, Norway, Mexico, Austria, Denmark, Germany, Hungary, Greece, France, Spain
-
AstraZenecaTerminatedType 2 Diabetes MellitusPhilippines
-
Shanghai Jiao Tong University School of MedicineUnknown
-
The University of Texas Medical Branch, GalvestonWithdrawn
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesKorea, Republic of, United Kingdom, Australia, Canada, Thailand, India
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesKorea, Republic of, Russian Federation, United Kingdom, Vietnam, Germany, Hungary, Finland, Norway, Netherlands, Slovakia, India
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesKorea, Republic of, China, India
-
AstraZenecaCompletedBioequivalence, Log-transformed AUCss and Cmax,ss Values for Saxagliptin and MetforminUnited States
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes MellitusFrance, Italy, Turkey, Germany, United Kingdom, Belgium, Spain
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesUnited States, Peru, Mexico, Colombia, Costa Rica
-
AstraZenecaBristol-Myers SquibbCompleted
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesKorea, Republic of, Philippines, China, India
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesCroatia, United States, Bulgaria, Czech Republic, Poland, Russian Federation, Belarus, Estonia, Germany, Hungary, Latvia, Lithuania, Romania, Ukraine
-
ikfe-CRO GmbHAstraZeneca; IKFE Institute for Clinical Research and DevelopmentUnknownDiabetes Mellitus, Type 2Germany
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesMexico, South Africa, Norway, Argentina, Belgium, Denmark, Sweden, France, Italy
-
AstraZenecaBristol-Myers SquibbCompleted
-
MovetisCompletedChronic Constipation
-
MovetisCompleted
-
MovetisCompleted